Free Trial

KalVista Pharmaceuticals (KALV) Insider Trading & Ownership

KalVista Pharmaceuticals logo
$26.70 -0.01 (-0.02%)
As of 12:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

KalVista Pharmaceuticals (NASDAQ:KALV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$6.07M
Get KALV Insider Trade Alerts

Want to know when executives and insiders are buying or selling KalVista Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KALV Insider Buying and Selling by Quarter

KalVista Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/17/2026Sell9,550$20.22$193,101.00  
4/17/2026Sell1,862$20.22$37,649.64  
4/17/2026Sell1,862$20.22$37,649.64  
4/17/2026Sell2,686$20.22$54,310.92  
3/26/2026
Venrock Healthcare Capital Par
Major Shareholder
Sell39,986$18.28$730,944.08  
3/25/2026
Venrock Healthcare Capital Par
Major Shareholder
Sell174,645$16.95$2,960,232.75  
3/9/2026Sell6,693$16.08$107,623.44  
2/23/2026Sell10,034$15.57$156,229.38  
2/23/2026Sell1,767$15.57$27,512.19  
2/23/2026Sell3,975$15.57$61,890.75  
2/23/2026Sell5,354$15.57$83,361.78  
2/18/2026Sell1,038$15.00$15,570.00  
2/18/2026Sell1,163$15.00$17,445.00  
2/12/2026Sell3,354$15.70$52,657.80  
12/8/2025Sell7,294$16.51$120,423.94  
11/24/2025Sell10,940$13.45$147,143.00  
11/24/2025Sell4,471$13.45$60,134.95  
11/24/2025Sell5,296$13.45$71,231.20  
11/12/2025Sell3,328$11.55$38,438.40  
9/8/2025Sell7,294$15.84$115,536.96  
8/25/2025Sell1,480$13.42$19,861.60  
8/25/2025Sell2,336$13.42$31,349.12  
8/22/2025Sell10,940$13.22$144,626.80  
8/22/2025Sell1,864$13.22$24,642.08  
8/22/2025Sell2,942$13.22$38,893.24  
7/9/2025Sell32,979$15.69$517,440.51  
6/9/2025Sell7,169$14.50$103,950.50  
5/23/2025Sell2,146$11.31$24,271.26  
5/19/2025Sell3,808$11.84$45,086.72  
5/19/2025Sell2,776$11.84$32,867.84  
(Data available from 1/1/2013 forward)

KALV Insider Trading Activity - Frequently Asked Questions

The list of insiders at KalVista Pharmaceuticals includes Albert Cha, Benjamin L Palleiko, Brian Piekos, Christopher Yea, Edward P Feener, Nicole Sweeny, Paul K Audhya, Thomas Andrew Crockett, and Venrock Healthcare Capital Par. Learn more on insiders at KALV.

4.30% of KalVista Pharmaceuticals stock is owned by insiders. Learn more on KALV's insider holdings.

The following insider purchased KALV shares in the last 24 months: Venrock Healthcare Capital Par ($2,397,646.35).

Insiders have purchased a total of 261,055 KALV shares in the last 24 months for a total of $2,397,646.35 bought.

The following insiders have sold KALV shares in the last 24 months: Benjamin L Palleiko ($2,700,137.23), Brian Piekos ($125,296.78), Christopher Yea ($85,295.02), Edward P Feener ($95,114.88), Nicole Sweeny ($144,044.07), Paul K Audhya ($531,258.45), and Venrock Healthcare Capital Par ($3,691,176.83).

Insiders have sold a total of 488,931 KalVista Pharmaceuticals shares in the last 24 months for a total of $7,372,323.26 sold.



This page (NASDAQ:KALV) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners